Novartis Vaccines, Siena, Italy.
Novartis Vaccines, Siena, Italy
EMBO Mol Med. 2014 Jun;6(6):708-20. doi: 10.1002/emmm.201403876. Epub 2014 Apr 6.
In the last century, vaccination has been the most effective medical intervention to reduce death and morbidity caused by infectious diseases. It is believed that vaccines save at least 2-3 million lives per year worldwide. Smallpox has been eradicated and polio has almost disappeared worldwide through global vaccine campaigns. Most of the viral and bacterial infections that traditionally affected children have been drastically reduced thanks to national immunization programs in developed countries. However, many diseases are not yet preventable by vaccination, and vaccines have not been fully exploited for target populations such as elderly and pregnant women. This review focuses on the state of the art of recent clinical trials of vaccines for major unmet medical needs such as HIV, malaria, TB, and cancer. In addition, we describe the innovative technologies currently used in vaccine research and development including adjuvants, vectors, nucleic acid vaccines, and structure-based antigen design. The hope is that thanks to these technologies, more diseases will be addressed in the 21st century by novel preventative and therapeutic vaccines.
在上个世纪,疫苗接种是减少传染病导致的死亡和发病的最有效医学干预手段。人们相信,疫苗每年在全球范围内至少挽救了 200 至 300 万人的生命。通过全球疫苗接种活动,天花已被根除,小儿麻痹症在全球范围内几乎消失。由于发达国家的国家免疫规划,大多数传统上影响儿童的病毒和细菌性感染已大大减少。然而,许多疾病仍然无法通过疫苗预防,并且疫苗在目标人群(如老年人和孕妇)中的应用尚未得到充分发挥。本综述重点介绍了针对重大未满足医疗需求的疫苗的最新临床试验现状,例如艾滋病毒、疟疾、结核病和癌症。此外,我们还描述了目前在疫苗研发中使用的创新技术,包括佐剂、载体、核酸疫苗和基于结构的抗原设计。希望在 21 世纪,由于这些技术的应用,更多的疾病将通过新型预防和治疗性疫苗得到解决。